KY Biotechnology & Medical Research

Adlai Nortye Ltd (ANL)

Track

Adlai Nortye Ltd experienced a single insider transaction during the past ninety days. CEO Lu Yang executed a sale of ten shares, totaling 131.8 USD. This divestment represents the sole activity recorded, occurring while the stock price maintains a position near its yearly peak despite limited volatility.
Ticker: ANL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 13 May 2026
Value US$4,570,107.76 | Price 80.91 | Shares 26,533 (+36.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-13 S Sale
LU YANG

CEO

Executive Director Large shareholder
26,533 +36.5%
80.91
US$4,570,108 		26,533 +36.5% 80.91 US$4,570,108
Explore more

More insider trading research around Adlai Nortye Ltd

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity